Date published: 2025-9-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

Mafenide Acetate (CAS 13009-99-9)

0.0(0)
Write a reviewAsk a question

Alternate Names:
4-(Aminomethyl)benzenesulfonamide Acetate; α-Amino-p-toluenesulfonamide; Sulfamylon Acetate
Application:
Mafenide Acetate is an antibacterial
CAS Number:
13009-99-9
Purity:
≥99%
Molecular Weight:
246.28
Molecular Formula:
C7H10N2O2S• C2H4O2
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Mafenide acetate, a derivative of sulfonamide, has been extensively studied in scientific research due to its potent antimicrobial properties and unique mechanism of action against bacteria. Upon application, mafenide acetate penetrates bacterial cell membranes and disrupts the synthesis of dihydropteroate synthetase, a key enzyme involved in folate biosynthesis. By inhibiting folate production, mafenide acetate effectively impedes bacterial growth and proliferation. In research settings, this chemical has been utilized to investigate bacterial resistance mechanisms and to develop novel strategies for combating antibiotic-resistant pathogens. Additionally, mafenide acetate has found applications in studying wound healing processes, particularly in the context of burn injuries, where its antimicrobial activity aids in preventing infections and promoting tissue regeneration. Moreover, research has explored the potential of mafenide acetate-based formulations for use in antimicrobial coatings and wound dressings, offering innovative approaches to prevent infections in clinical settings. Overall, mafenide acetate serves as a valuable tool for advancing our understanding of antimicrobial pharmacology and developing effective interventions to address bacterial infections and antibiotic resistance.


Mafenide Acetate (CAS 13009-99-9) References

  1. Comparison of silver sulphadiazine 1 per cent, silver sulphadiazine 1 per cent plus chlorhexidine digluconate 0.2 per cent and mafenide acetate 8.5 per cent for topical antibacterial effect in infected full skin thickness rat burn wounds.  |  Gray, JH., et al. 1991. Burns. 17: 37-40. PMID: 2031672
  2. In vitro toxicity and activity of Dakin's solution, mafenide acetate, and amphotericin B on filamentous fungi and human cells.  |  Barsoumian, A., et al. 2013. J Orthop Trauma. 27: 428-36. PMID: 23287750
  3. Hydrofiber Dressing Saturated With Mafenide Acetate Extends the Duration of Antimicrobial Activity.  |  Kahn, SA., et al. 2017. J Burn Care Res. 38: e704-e707. PMID: 27775984
  4. In vitro toxicity of topical antimicrobial agents to human fibroblasts.  |  McCauley, RL., et al. 1989. J Surg Res. 46: 267-74. PMID: 2921865
  5. Comparison of standard and chlorhexidine-derivative topical antibacterial agents on the infected burned rat wound.  |  Snelling, CF., et al. 1988. Burns Incl Therm Inj. 14: 91-100. PMID: 3134114
  6. The effects of topical mafenide acetate application on skin graft survival in bacterial contaminated wounds.  |  Baver Acaban, M., et al. 2024. Burns. 50: 433-443. PMID: 37985270
  7. The effect of 5% mafenide acetate solution on bacterial control in infected rat burns.  |  Murphy, RC., et al. 1983. J Trauma. 23: 878-81. PMID: 6415293
  8. Cytoprotection of human dermal fibroblasts against silver sulfadiazine using recombinant growth factors.  |  McCauley, RL., et al. 1994. J Surg Res. 56: 378-84. PMID: 8152234
  9. Topical sulfamylon reduces engraftment of cultured skin substitutes on athymic mice.  |  Boyce, ST., et al. 1999. J Burn Care Rehabil. 20: 33-6. PMID: 9934634

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Mafenide Acetate, 25 mg

sc-211760
25 mg
$260.00